William O Rogers
Overview
Explore the profile of William O Rogers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1967
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lek D, Rachmat A, Harrison D, Chin G, Chaoratanakawee S, Saunders D, et al.
Malar J
. 2022 Sep;
21(1):259.
PMID: 36071520
Background: Anti-malarial resistance remains an important public health challenge in Cambodia. The effectiveness of three therapies for uncomplicated falciparum malaria was evaluated in Oddar Meanchey province in Northern Cambodia from...
2.
Immune Signature Against Antigens Predicts Clinical Immunity in Distinct Malaria Endemic Communities
Proietti C, Krause L, Trieu A, Dodoo D, Gyan B, Koram K, et al.
Mol Cell Proteomics
. 2019 Oct;
19(1):101-113.
PMID: 31658979
A large body of evidence supports the role of antibodies directed against the parasite in the development of naturally acquired immunity to malaria, however an antigen signature capable of predicting...
3.
Lek D, Popovici J, Ariey F, Vinjamuri S, Meek S, Bruce J, et al.
Am J Trop Med Hyg
. 2016 Jul;
95(3):588-94.
PMID: 27402511
Accurate information regarding malaria prevalence at national level is required to design and assess malaria control/elimination efforts. Although many comparisons of microscopy and polymerase chain reaction (PCR)-based methods have been...
4.
Parobek C, Bailey J, Hathaway N, Socheat D, Rogers W, Juliano J
PLoS Negl Trop Dis
. 2014 Apr;
8(4):e2796.
PMID: 24743266
Although Plasmodium vivax is a leading cause of malaria around the world, only a handful of vivax antigens are being studied for vaccine development. Here, we investigated genetic signatures of...
5.
Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A, Khim N, et al.
Nature
. 2013 Dec;
505(7481):50-5.
PMID: 24352242
Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide. To monitor the spread of artemisinin resistance, a molecular marker is urgently needed. Here,...
6.
Lin J, Patel J, Kharabora O, Sattabongkot J, Muth S, Ubalee R, et al.
Am J Trop Med Hyg
. 2013 Mar;
88(6):1116-23.
PMID: 23509126
Plasmodium vivax accounts for an increasing fraction of malaria infections in Thailand and Cambodia. We compared P. vivax genetic complexity and antimalarial resistance patterns in the two countries. Use of...
7.
Richie T, Charoenvit Y, Wang R, Epstein J, Hedstrom R, Kumar S, et al.
Hum Vaccin Immunother
. 2012 Nov;
8(11):1564-84.
PMID: 23151451
When introduced in the 1990s, immunization with DNA plasmids was considered potentially revolutionary for vaccine development, particularly for vaccines intended to induce protective CD8 T cell responses against multiple antigens....
8.
Ghansah A, Rockett K, Clark T, Wilson M, Koram K, Oduro A, et al.
PLoS One
. 2012 Apr;
7(4):e34565.
PMID: 22506028
Background: Haemoglobin S (HbS) and C (HbC) are variants of the HBB gene which both protect against malaria. It is not clear, however, how these two alleles have evolved in...
9.
Lin J, Juliano J, Kharabora O, Sem R, Lin F, Muth S, et al.
J Clin Microbiol
. 2011 Dec;
50(4):1449-51.
PMID: 22205791
Using a newly developed Plasmodium vivax merozoite surface protein 1 gene (Pvmsp1) heteroduplex tracking assay, we genotyped 107 P. vivax infections in individuals from Cambodia, 45 of whom developed recurrent...
10.
Dodoo D, Hollingdale M, Anum D, Koram K, Gyan B, Akanmori B, et al.
Malar J
. 2011 Jun;
10:168.
PMID: 21689436
Background: To prepare field sites for malaria vaccine trials, it is important to determine baseline antibody and T cell responses to candidate malaria vaccine antigens. Assessing T cell responses is...